Regeneron Pharmaceuticals Regeneron Full Year Revenue Totals $14.34 Billion 10 hours ago Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares declined 2.61% during Friday’s trading session, following the release of the company’s fourth-quarter and…